Welcome to our dedicated page for Kandi Technologies Group news (Ticker: $KNDI), a resource for investors and traders seeking the latest updates and insights on Kandi Technologies Group stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kandi Technologies Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kandi Technologies Group's position in the market.
Kandi Technologies (NASDAQ: KNDI) reported its Q1 2024 financial results, highlighting a net income of $0.8 million, up 27.6% YoY. Total revenues were $20.7 million, down 9.6% from $22.9 million the previous year. Gross profit fell by 11.3% to $7.1 million, with a gross margin of 34.5%. Operating expenses slightly decreased to $10.2 million, while loss from operations increased by 38% to $3.1 million. The company repurchased 564,302 shares, showcasing confidence in its future. Expansion efforts in North America, Southeast Asia, and Europe are underway, with new product launches planned.
Kandi Technologies Group (NASDAQ GS: KNDI) will announce its first quarter 2024 financial results on May 16, 2024. The company has also scheduled a conference call and live webcast for 8:00 A.M. Eastern Time (8:00 P.M. Beijing Time) on the same day. Management will provide remarks followed by a Q&A session. Dial-in details for the call include a toll-free number (+1-877-407-3982) and an international number (+1-201-493-6780). A live audio webcast and replay will be available at Kandi's Investor Relations website.